Lysophospholipids: Two-Faced Mediators In Atherosclerosis

Bibliography

• 1. Gennero I, Xuereb JM, Simon MF et al.: Effects of lysophosphatidic acid on proliferation and cytosolic Ca2+ of human adult vascular smooth muscle cells in culture. Thromb. Res. 94, 317–326 (1999).
   Google Scholar
• Natarajan V, Scribner WM, Hart CM, Parthasarathy S: Oxidized low density lipoprotein-mediated activation of phospholipase D in smooth muscle cells: a possible role in cell proliferation and atherogenesis. J. Lipid Res. 36, 2005–2016 (1995).
   Google Scholar
• Tokumura A, Iimori M, Nishioka Y, Kitahara M, Sakashita M, Tanaka S: Lysophosphatidic acids induce proliferation of cultured vascular smooth muscle cells from rat aorta. Am. J. Physiol. 267, C204–C210 (1994).
   Google Scholar
• Moolenaar WH: Lysophosphatidic acid signalling. Curr. Opin. Cell Biol. 7, 203–210 (1995).
   Google Scholar
• Siess W, Zangl KJ, Essler M et al.: Lysophosphatidic acid mediates the rapid activation of platelets and endothelial cells by mildly oxidized low density lipoprotein and accumulates in human atherosclerotic lesions. Proc. Natl Acad. Sci. USA 96, 6931–6936 (1999).
   Google Scholar
• First paper to identify lysophosphatidic acid (LPA), accumulated in human atherosclerotic lesions, as a major thrombogenic agent and to establish its effects on platelets.
   Google Scholar
• Haserück N, Erl W, Pandey D et al.: The plaque lipid lysophosphatidic acid stimulates platelet activation and platelet–monocyte aggregate formation in whole blood: involvement of P2Y1 and P2Y12 receptors. Blood 103, 2585–2592 (2004).
   Google Scholar
• Ridley AJ, Hall A: The small GTP-binding protein rho regulates the assembly of focal adhesions and actin stress fibers in response to growth factors. Cell 70, 389–399 (1992).
   Google Scholar
• Fukushima N, Kimura Y, Chun J: A single receptor encoded by Vzg-1/LPA1/Edg-2 couples to G proteins and mediates multiple cellular responses to lysophosphatidic acid. Proc. Natl Acad. Sci. USA 95, 6151–6156 (1998).
   Google Scholar
• Contos JJ, Ishii I, Chun J: Lysophosphatidic acid receptors. Mol. Pharmacol. 58, 1188–1196 (2000).
   Google Scholar
• Ishii I, Fukushima N, Ye X, Chun J: Lysophospholipid receptors: signaling and biology. Annu. Rev. Biochem. 73, 321–354 (2004).
   Google Scholar
• Gobeil Jr F, Bernier SG, Vazquez-Tello A et al.: Modulation of pro-inflammatory gene expression by nuclear lysophosphatidic acid receptor type-1. J. Biol. Chem. 278(40), 37875–38883 (2003).
   Google Scholar
• Noguchi K, Ishii S, Shimizu T: Identification of p2y9/GPR23 as a novel G protein-coupled receptor for lysophosphatidic acid, structurally distant from the Edg family. J. Biol. Chem. 278(28), 25600–25606 (2003).
   Google Scholar
• Kotarsky K, Boketoft Å, Bristulf J et al.: Lysophosphatidic acid binds to and activates GPR92, a G protein-coupled receptor highly expressed in gastrointestinal lymphocytes. J. Pharmacol. Exp. Ther. 318(2), 619–628 (2006).
   Google Scholar
• McIntyre TM, Ponstler AV, Silva AR et al.: Identification of an intracellular receptor for lysophosphatidic acid (LPA): LPA is a transcellular PPAR agonist. Proc. Natl Acad. Sci. USA 100(1), 131–136 (2003).
   Google Scholar
• Highlights that LPA can exert its effects not only by interacting with extracellular but also with intracellular receptors.
   Google Scholar
• Anliker B, Chun J: Lysophospholipid G protein-coupled receptors. J. Biol. Chem. 279, 20555–20558 (2004).
   Google Scholar
• Uhlenbrock K, Gassenhuber H, Kostenis E: Sphingosine 1-phosphate is a ligand of the human GPR3, GPR6 and GPR12 family of constitutively active G protein-coupled receptors. Cell Signal. 14, 941–953 (2002).
   Google Scholar
• Niedernberg A, Tunaru S, Blaukat A, Ardati A, Kostenis E: Sphingosine 1-phosphate and dioleoylphosphatidic acid are low affinity agonists for the orphan receptor GPR63. Cell Signal. 15, 435–446 (2003). 18. Baker DL, Desiderio DM, Miller DD, Tolley B, Tigyi GJ: Direct quantitative analysis of lysophosphatidic acid molecular species by stable isotype dilution electrospray ionization liquid chromatography-mass spectrometry. Anal. Biochem. 292, 287–295 (2001).
   Google Scholar
• Provides a quantitative characterization of the LPA species present in human serum and plasma.
   Google Scholar
• Siess W, Tigyi G: Thrombogenic and atherogenic activities of lysophosphatidic acid. J. Cell Biochem. 92, 1086–1094 (2004).
   Google Scholar
• Moolenaar WH, van Meeteren LA, Giepmans BNG: The ins and outs of lysophosphatidic acid signalling. Bioessays 26, 870–881 (2004).
   Google Scholar
• Sano T, Baker D, Virag T et al.: Multiple mechanisms linked to platelet activation result in lysophosphatidic acid and sphingosine 1-phosphate generation in blood. J. Biol. Chem. 277(24), 21197–21206 (2002).
   Google Scholar
• Describes the main production pathways of LPA after platelet activation and refutes the prior notion that LPA is produced and secreted by platelets.
   Google Scholar
• Aoki J, Taira A, Takanezawa Y et al.: Serum lysophosphatidic acid is produced through diverse phospholipase pathways. J. Biol. Chem. 277(50), 48737–48744 (2002).
   Google Scholar
• Aoki J: Mechanisms of lysophosphatidic acid production. Semin. Cell Dev. Biol. 15(5), 477–489 (2004).
   Google Scholar
• Pyne S, Kong KC, Darroch PI: Lysophosphatidic acid and sphingosine 1-phosphate biology: the role of lipid phosphate phosphatases. Semin. Cell Dev. Biol. 15(5), 491–501 (2004).
   Google Scholar
• Haldar D, Vancura A: Glycerophosphate acyltransferase from liver. Methods Enzymol. 209, 64–72 (1992).
   Google Scholar
• Pagès C, Simon MF, Valet P, Saulnier-Blache JS: Lysophosphatidic acid synthesis and release. Prostaglandins Other Lipid Mediat. 64, 1–10 (2001).
   Google Scholar
• Eberhardt C, Gray PW, Tjoelker LW: Human lysophosphatidic acid acyltransferase. J. Biol. Chem. 272(32), 20299–20305 (1997).
   Google Scholar
• Yatomi Y, Igarashi Y, Yang L et al.: Sphingosine 1-phosphate, a bioactive sphingolipid abundantly stored in platelets, is a normal constituent of human plasma and serum. J. Biochem. 121, 969–973 (1997).
   Google Scholar
• Murata N, Sato K, Kon J, et al.: Interaction of sphingosine 1-phosphate with plasma components, including lipoproteins, regulates the lipid receptor-mediated actions. Biochem. J. 352, 809–815 (2000).
   Google Scholar
• Tamama K, Okajima F: Sphingosine 1-phosphate signaling in atherosclerosis and vascular biology. Curr. Opin. Lipidol. 13, 489–495 (2002).
   Google Scholar
• Taha TA, Hannun YA, Obeid LM: Sphingosine kinase: biochemical and cellular regulation and role in disease. J. Biochem. Mol. Biol. 39, 113–131 (2006).
   Google Scholar
• Maceyka M, Sankala H, Hait NC et al.: SphK1 and SphK2, sphingosine kinase isoenzymes with opposing functions in sphingolipid metabolism. J. Biol. Chem. 280(44), 37118–37129 (2005).
   Google Scholar
• Venkataraman K, Thangada S, Michaud J et al.: Extracellular export of sphingosine kinase-1a contributes to the vascular S1P gradient. Biochem. J. 397, 461–471 (2006).
   Google Scholar
• Clair T, Aoki J, Koh E et al.: Autotaxin hydrolyzes sphingosylphosphorylcholine to produce the regulator of migration, sphingosine-1-phosphate. Cancer Res. 63, 5446–5453 (2003).
   Google Scholar
• Spiegel S, Milstien S: Sphingosine 1-phosphate: an enigmatic signaling lipid. Nat. Rev. Mol. Cell Biol. 4, 397–407 (2003).
   Google Scholar
• Yatomi Y, Ohmori T, Rile G et al.: Sphingosine 1-phosphate as a major bioactive lysophospholipid that is released from platelets and interacts with endothelial cells. Blood 96, 3431–3438 (2000).
   Google Scholar
• This elegant study is the first to identify erythrocytes as a major source of sphingosine 1-phosphate (S1P) in plasma and casts doubt on the prevaling theory that plasma S1P originates from platelets.
   Google Scholar
• Hänel P, Andréani P, Gräler MH: Erythrocytes store and release sphingosine 1-phosphate in blood. FASEB J. 21(4), 1202–1209 (2007).
   Google Scholar
• In this study, the long sought after transplasma membrane S1P transporter has been identified as ATP binding cassette C1 – a protein previously recognized for its ability to export antitumor drugs and leukotriene C4.
   Google Scholar
• Mitra P, Oskeritzian CA, Payne SG, Beaven MA, Milstien S, Spiegel S: Role of ABCC1 in export of sphingosine-1-phosphate from mast cells. Proc. Natl Acad. Sci. USA 103(44), 16394–16399 (2006).
   Google Scholar
• Rosengren B, Peilot H, Jonsson-Rylander AC et al.: Secretory phospholipase A2 group V: lesion distribution, activation by arterial proteoglycans, and induction in aorta by a Western diet. Arterioscler. Thromb. Vasc. Biol. 26(7), 1579–1585 (2006).
   Google Scholar
• Moreno PR, Purushothaman KR, Sirol M, Levy AP, Fuster V: Neovascularization in human atherosclerosis. Circulation 113, 2245–2252 (2006).
   Google Scholar
• Siess W: Athero- and thrombogenic actions of lysophosphatidic acid and sphingosine-1- phosphate. Biochim. Biophys. Acta 1582, 204–215 (2002).
   Google Scholar
• Simon MF, Chap H, Douste-Blazy L: Human platelet aggregation induced by 1-alkyl-lysophosphatidic acid and its analogs: a new group of phospholipid mediators? Biochem. Biophys. Res. Com. 108(4), 1743–1750 (1982).
   Google Scholar
• Tokumura A, Sinomiya J, Kishimoto S et al.: Human platelets respond differentially to lysophosphatidic acids having a highly unsaturated fatty acyl group and alkyl ether-linked lysophosphatidic acids. Biochem. J. 365, 617–628 (2002).
   Google Scholar
• Rother E, Brandl R, Baker DL et al.: Subtype-selective antagonists of lysophosphatidic acid receptors inhibit platelet activation triggered by the lipid core of atherosclerotic plaques. Circulation 108, 741–747 (2003).
   Google Scholar
• Van Nieuw Amerongen GP, Vermeer MA, Hinsbergh VWM: Role of rhoA and rho kinase in lysophosphatidic acid-induced endothelial barrier dysfunction. Arterioscler. Thromb. Vasc. Biol. 20, E127–E133 (2000).
   Google Scholar
• Palmetshofer A, Robson SC, Nehls V: Lysophosphatidic acid activates nuclear factor- B and induces proinflammatory gene expression in endothelial cells. Thromb. Haemost. 82, 1532–1537 (1999).
   Google Scholar
• Rizza C, Leitinger N, Yue J et al.: Lysophosphatidic acid as a regulator of endothelial/leukocyte interaction. Lab. Invest. 79, 1227–1235 (1999).
   Google Scholar
• Gräler M, Goetzl EJ: Lysophospholipids and their G protein-coupled receptors in inflammation and immunity. Biochim. Biophys. Acta 1582, 168–174 (2002).
   Google Scholar
• Bagga S, Price KS, Lin DA, Friend DS, Austen KF, Boyce JA: Lysophosphatidic acid accelerates the development of human mast cells. Blood 104(13), 4080–4087 (2004).
   Google Scholar
• Fueller M, Wang DA, Tigyi G, Siess W: Activation of human monocytic cells by lysophosphatidic acid and sphingosine- 1-phosphate. Cell Signal. 15, 367–375 (2003).
   Google Scholar
• D’Aquilio F, Procaccini M, Izzi V et al.: Activatory properties of lysophosphatidic acid on human THP-1 cells. Inflammation 29(4–6), 129–140 (2005).
   Google Scholar
• Llodrá J, Angeli V, Liu J, Trogan E, Fisher EA, Randolph GJ: Emigration of monocyte-derived cells from atherosclerotic lesions characterizes regressive, but not progressive, plaques. Proc. Natl Acad. Sci. USA 101(32), 11779–11784 (2004).
   Google Scholar
• Weber C, Alon R, Moser B, Springer TA: Sequential regulation of 4 1 and 5 1 integrin avidity by CC chemokines in monocytes: implications for transendothelial chemotaxis. J. Cell Biol. 134(4) 1063–1073 (1996).
   Google Scholar
• Doherty TM, Fisher EA, Arditi M: TLR signalling and trapped vascular dendritic cells in the development of atherosclerosis. Trends Immunol. 27(5), 222–227 (2006).
   Google Scholar
• Panther E, Idzko M, Corinti S et al.: The influence of lysophosphatidic acid on the functions of human dendritic cells. J. Immunol. 169, 4129–4135 (2002).
   Google Scholar
• Renkl A, Berod L, Mockenhaupt M et al.: Distinct effects of sphingosine 1-phosphate, lysophosphatidic acid and histamine in human and mouse dendritic cells. Int. J. Mol. Med. 13, 203–209 (2004).
   Google Scholar
• Chen R, Roman J, Guo J et al.: Lysophosphatidic acid modulates the activation of human monocyte-derived dendritic cells. Stem Cells Dev. 15(6), 797–804 (2006).
   Google Scholar
• Kaartinen M, Pentillä A, Kovanen PT: Mast cells accompany microvessels in human coronary atheromas: implications for intimal neovascularization and hemorrhage. Atherosclerosis 123(1–2), 123–131 (1996).
   Google Scholar
• Hashimoto T, Ohata H, Honda K: Lysophosphatidic acid induces plasma exudation and histamine release in mice via lysophosphatidic acid receptors. J. Pharmacol. Sci. 100(1), 82–87 (2006).
   Google Scholar
• Lin DA, Boyce JA: IL-4 regulates MEK expression required for lysophophatidic acid-mediated chemokine generation by human mast cells. J. Immunol. 175, 5430–5438 (2005).
   Google Scholar
• Hayashi K, Takahashi M, Nishida W et al.: Phenotypic modulation of vascular smooth muscle cells induced by unsaturated lysophosphatidic acids. Circ. Res. 89, 251–258 (2001).
   Google Scholar
• Ai S, Kuzuya M, Koike T et al.: Rho–Rho kinase is involved in smooth muscle cell migration through myosin light chain phosphorylation-dependent and independent pathways. Atherosclerosis 155, 321–327 (2001).
   Google Scholar
• Cui MZ, Zhao G, Winokur AL et al.: Lysophosphatidic acid induction of tissue factor expression in aortic smooth muscle cells. Arterioscler. Thromb. Vasc. Biol. 23, 224–230 (2003).
   Google Scholar
• Conclusively established that LPA can, via peroxisome proliferator-activated receptor (PPAR)γ activation, influence vascular tissue remodeling, which is of great importance in atherosclerotic lesion development.
   Google Scholar
• Zhang C, Baker DL, Yasuda S et al.: Lysophosphatidic acid induces neointima formation through PPAR activation. J. Exp. Med. 199(6), 763–774 (2004).
   Google Scholar
• Conclusively established that LPA can, via PPARγ activation, influence vascular tissue remodeling, which is of great importance in atherosclerotic lesion development.
   Google Scholar
• Yoshida K, Nishida W, Hayashi K et al.: Vascular remodeling induced by naturally occurring unsaturated lysophosphatidic acid in vivo. Circulation 108, 1746–1752 (2003).
   Google Scholar
• Keul P, Tolle M, Lucke S et al.: The sphingosine-1-phosphate analogue FTY720 reduces atherosclerosis in apolipoprotein E-deficient mice. Arterioscler. Thromb. Vasc. Biol. 27(3), 607–613 (2007).
   Google Scholar
• These reports are the first to demonstrate the atheroprotective effect of a synthetic S1P analogue, FTY720, in two distinct animal models of disease.
   Google Scholar
• Nofer JR, Bot M, Brodde M et al.: FTY720, a synthetic sphingosine 1-phosphate (S1P) analogue, inhibits development of atherosclerosis in low-density lipoprotein receptor-deficient mice. Circulation 115(4), 501–508 (2007).
   Google Scholar
• Payne SG, Oskeritzian CA, Griffiths R et al.: The immunosuppressant drug FTY720 inhibits cytosolic phospholipase A2 independently of sphingosine 1-phoshate receptors. Blood 109(3), 1077–1085 (2007).
   Google Scholar
• Gräler MH, Shankar G, Goetzl EJ: Cutting edge: suppression of T cell chemotaxis by sphingosine 1-phosphate. J. Immunol. 169, 4084–4087 (2002).
   Google Scholar
• Gräler MH, Huang MC, Watson S, Goetzl EJ: Immunological effects of transgenic constitutive expression of the type 1 sphingosine 1-phosphate receptor by mouse lymphocytes. J. Immunol. 174, 1997–2003 (2005).
   Google Scholar
• Paust S, Cantor H: Regulatory T cells and autoimmune disease. Immunol. Rev. 204, 195–207 (2005).
   Google Scholar
• Wang W, Graeler M, Goetzl EJ: Physiological sphingosine 1-phosphate requirement for optimal activity of mouse CD4+ regulatory T cells. FASEB J. 18, 1043–1045 (2004).
   Google Scholar
• Ait-Oufella H, Salomon BL, Potteaux S et al.: Natural regulatory T cells control the development of atherosclerosis in mice. Nat. Med. 12(2), 78–80 (2006).
   Google Scholar
• Rosen H, Goetzl EJ: Sphingosine 1-phosphate and its receptors: an autocrine and paracrine network. Nat. Rev. Immunol. 5(7), 560–570 (2005).
   Google Scholar
• Mandala S, Hajdu R, Bergstrom J et al.: Alteration of lymphocyte trafficking by sphingosine-1-phosphate receptor agonists. Science 296, 346–349 (2002).
   Google Scholar
• Wei SH, Rosen H, Matheu MP et al.: Sphingosine 1-phosphate type 1 receptor agonism inhibits transendothelial migration of medullary T cells to lymphatic sinuses. Nat. Immunol. 6, 1228–1235 (2005).
   Google Scholar
• Klingenberg R, Bea F, Blessing E et al.: The immunomodulator FTY720 inhibits early atherosclerosis in ApoE-/- mice. Atherosclerosis 7, 276 (2006).
   Google Scholar
• Duong CQ, Bared SM, Abu-Khader A, Buechler C, Schmitz A, Schmitz G: Expression of the lysophospholipid receptor family and investigation of lysophospholipid-mediated responses in human macrophages. Biochim. Biophys. Acta 1682, 112–119 (2004).
   Google Scholar
• Gomez-Munoz A, Kong J, Salh B, Steinbrecher UP: Sphingosine-1-phosphate inhibits acid sphingomyelinase and blocks apoptosis in macrophages. FEBS Lett. 539, 56–60 (2003).
   Google Scholar
• Weigert A, Johann AM, von Knethen A, Schmidt H, Geisslinger G, Brune B: Apoptotic cells promote macrophage survival by releasing the antiapoptotic mediator sphingosine-1-phosphate. Blood 108, 1635–1642 (2006).
   Google Scholar
• Stoneman VE, Bennett MR: Role of apoptosis in atherosclerosis and its therapeutic implications. Clin. Sci. (Lond). 107, 343–354 (2004).
   Google Scholar
• Eigenbrod S, Derwand R, Jakl V, Endres S, Eigler A: Sphingosine kinase a nd sphingosine 1-phosphate regulate migration, endocytosis and apoptosis of dendritic cells. Immunol. Invest. 35, 149–165 (2006).
   Google Scholar
• Olivera A, Mizugishi K, Tikhonova A et al.: The sphingosine kinase-sphingosine-1- phosphate axis is a determinant of mast cell function and anaphylaxis. Immunity 26, 287–297 (2007).
   Google Scholar
• Jolly PS, Bektas M, Olivera A et al.: Transactivation of sphingosine-1-phosphate receptors by FC RI triggering is required for normal mast cell degranulation and chemotaxis. J. Exp. Med. 199(7), 959–970 (2004).
   Google Scholar
• Kluk MJ, Hla T: Signaling of sphingosine-1-phosphate via the S1P/EDG-family of G-protein-coupled receptors. Biochim. Biophys. Acta 1582, 72–80 (2002).
   Google Scholar
• Garcia JG, Liu F, Verin AD et al.: Sphingosine 1-phosphate promotes endothelial cell barrier integrity by Edg-dependent cytoskeletal rearrangement. J. Clin. Invest. 108, 689–701 (2001).
   Google Scholar
• Peng X, Hassoun PM, Sammani S et al.: Protective effects of sphingosine 1-phosphate in murine endotoxin-induced inflammatory lung injury. Am. J. Respir. Crit. Care Med. 169, 1245–1251 (2004).
   Google Scholar
• Dudek SM, Peng X, Birukov KG et al.: Mechanisms of sphingosine 1-phosphate mediated lung vascular barrier enhancement in vivo and in vitro. J. Biol. Chem. 279(23), 24692–24700 (2004).
   Google Scholar
• Singleton PA, Dudek SM, Chiang ET, Garcia JG: Regulation of sphingosine 1-phosphate-induced endothelial cytoskeletal rearrangement and barrier enhancement by S1P1 receptor, PI3 kinase, Tiam1/Rac1, and -actinin. FASEB J. 19, 1646–1656 (2005).
   Google Scholar
• Singleton PA, Dudek SM, Ma SF, Garcia JG: Transactivation of sphingosine-1-phosphate receptors is essential for vascular barrier regulation: novel role for hyaluronan and CD44 receptor family. J. Biol. Chem. 281(45), 34381–34391 (2006).
   Google Scholar
• Kimura T, Watanabe T, Sato K et al.: Sphingosine 1-phosphate stimulates proliferation and migration of human endothelial cells possibly through the lipid receptors, Edg-1 and Edg-3. Biochem. J. 348, 71–76 (2000).
   Google Scholar
• Kimura T, Sato K, Malchinkhuu E et al.: High-density lipoprotein stimulates endothelial cell migration and survival through sphingosine 1-phosphate and its receptors. Arterioscler. Thromb. Vasc. Biol. 23, 1283–1288 (2003).
   Google Scholar
• Panetti TS, Nowlen J, Mosher DF: Sphingosine-1-phosphate and lysophosphatidic acid stimulate endothelial cell migration. Arterioscler. Thromb. Vasc. Biol. 20, 1013–1019 (2000).
   Google Scholar
• Sanchez T, Thangada S, Wu MT et al.: PTEN as an effector in the signaling of antimigratory G protein-coupled receptor. Proc. Natl Acad. Sci. USA 102, 4312–4317 (2005).
   Google Scholar
• Paik JH, Chae S, Lee MJ, Thangada S, Hla T: Sphingosine 1-phosphate-induced endothelial cell migration requires the expression of Edg-1 and Edg-3 receptors and Rho-dependent activation of v 3- and 1-containing integrins. J. Biol. Chem. 276, 11830–11837 (2001).
   Google Scholar
• Walter DH, Rochwalsky U, Reinhold J et al.: Sphingosine-1-phosphate stimulates the functional capacity of progenitor cells by activation of the CXCR4-dependent signaling pathway via the S1P3 receptor. Arterioscler. Thromb. Vasc. Biol. 27(2), 275–282 (2007).
   Google Scholar
• Miura S, Tanigawa H, Matsuo Y, Fujino M, Kawamura A, Saku K: Ras/Raf1-dependent signal in sphingosine-1-phosphate-induced tube formation in human coronary artery endothelial cells. Biochem. Biophys. Res. Commun. 306, 924–929 (2003).
   Google Scholar
• Matsuo Y, Miura SI, Kawamura A, Uehara Y, Rye KA, Saku K. Newly developed reconstituted high-density lipoprotein containing sphingosine-1-phosphate induces endothelial tube formation. Atherosclerosis (2007) (Epub ahead of print).
   Google Scholar
• Fieber CB, Eldridge J, Taha TA, Obeid LM, Muise-Helmericks RC: Modulation of total Akt kinase by increased expression of a single isoform: requirement of the sphingosine-1-phosphate receptor, Edg3/S1P3, for the VEGF-dependent expression of Akt3 in primary endothelial cells. Exp. Cell Res. 312, 1164–1173 (2006).
   Google Scholar
• Nofer JR, van der Giet M, Tolle M et al.: HDL induces NO-dependent vasorelaxation via the lysophospholipid receptor S1P3. J. Clin. Invest. 113, 569–581 (2004).
   Google Scholar
• Tolle M, Levkau B, Keul P et al.: Immunomodulator FTY720 induces eNOS-dependent arterial vasodilatation via the lysophospholipid receptor S1P3. Circ. Res. 96, 913–920 (2005).
   Google Scholar
• Kimura T, Tomura H, Mogi C et al.: Sphingosine 1-phosphate receptors mediate stimulatory and inhibitory signalings for expression of adhesion molecules in endothelial cells. Cell Signal. 18, 841–850 (2006).
   Google Scholar
• Bolick DT, Srinivasan S, Kim KW et al.: Sphingosine-1-phosphate prevents tumor necrosis factor- mediated monocyte adhesion to aortic endothelium in mice. Arterioscler. Thromb. Vasc. Biol. 25, 976–981 (2005).
   Google Scholar
• Whetzel AM, Bolick DT, Srinivasan S et al.: Sphingosine-1 phosphate prevents monocyte/endothelial interactions in type 1 diabetic NOD mice through activation of the S1P1 receptor. Circ. Res. 99, 731–739 (2006).
   Google Scholar
• Lockman K, Hinson JS, Medlin MD, Morris D, Taylor JM, Mack CP: Sphingosine 1-phosphate stimulates smooth muscle cell differentiation and proliferation by activating separate serum response factor co-factors. J. Biol. Chem. 279, 42422–42430 (2004).
   Google Scholar
• Tanimoto T, Lungu AO, Berk BC: Sphingosine 1-phosphate transactivates the platelet-derived growth factor receptor and epidermal growth factor receptor in vascular smooth muscle cells. Circ. Res. 94, 1050–1058 (2004).
   Google Scholar
• Waters CM, Long J, Gorshkova I et al.: Cell migration activated by platelet-derived growth factor receptor is blocked by an inverse agonist of the sphingosine 1-phosphate receptor-1. FASEB J. 20, 509–511 (2006).
   Google Scholar
• Ryu Y, Takuwa N, Sugimoto N et al.: Sphingosine-1-phosphate, a platelet-derived lysophospholipid mediator, negatively regulates cellular Rac activity and cell migration in vascular smooth muscle cells. Circ. Res. 90, 325–332 (2002).
   Google Scholar
• Tamama K, Tomura H, Sato K et al.: High-density lipoprotein inhibits migration of vascular smooth muscle cells through its sphingosine 1-phosphate component. Atherosclerosis 178, 19–23 (2005).
   Google Scholar
• Pettus BJ, Bielawski J, Porcelli AM et al.: The sphingosine kinase 1/sphingosine-1- phosphate pathway mediates COX-2 induction and PGE2 production in response to TNF . FASEB J. 17, 1411–1421 (2003).
   Google Scholar
• Elegantly delineates the astonishingly complex interplay between S1P and ceramide 1-phosphate, another extra- and intracellular bioactive lipid, in the regulation of cyclooxygenase-2-mediated production of proinflammatory mediators.
   Google Scholar
• Pettus BJ, Kitatani K, Chalfant CE et al.: The coordination of prostaglandin E2 production by sphingosine-1-phosphate and ceramide-1-phosphate. Mol. Pharmacol. 68(2), 330–335 (2005).
   Google Scholar
• Elegantly delineates the astonishingly complex interplay between S1P and ceramide 1-phosphate, another extra- and intracellular bioactive lipid, in the regulation of cyclooxygenase-2-mediated production of proinflammatory mediators.
   Google Scholar
• Corcoran ML, Stetler-Stevenson WG, DeWitt DL et al.: Effect of cholera toxin and pertussis toxin on prostaglandin H synthase-2, prostaglandin E2 and matrix metalloproteinases production by human monocytes. Arch. Biochem. Biophys. 310, 481–488 (1994).
   Google Scholar
• Elegantly delineates the astonishingly complex interplay between S1P and ceramide 1-phosphate, another extra- and intracellular bioactive lipid, in the regulation of cyclooxygenase-2-mediated production of proinflammatory mediators.
   Google Scholar
• Cipollone F, Fazia ML: COX-2 and atherosclerosis. J. Cardiovasc. Pharmacol. 47(Suppl. 1), S26–S36 (2006).
   Google Scholar
• Ki SH, Choi MJ, Lee CH, Kim SG: G 12 specifically regulates COX-2 induction by sphingosine 1-phosphate: role for JNK-dependent ubiguitination and degradation of I B . J. Biol. Chem. 282(3), 1983–1947 (2007).
   Google Scholar